How American Pharma Companies are Addressing Global Health Challenges?
Kate Williamson, Editorial Team, Pharma Focus America
America boasts of several pharmaceutical industries that are very vital in meeting the world’s health needs, research, collaborations, and other advanced technologies in the health sector. Providing access to life-saving drugs and identifying ways of combating infectious as well as chronic diseases, these companies are enhancing the quality of people’s lives on a global scale and meaningfully contributing to the issue of health inequality and overall health systems’ stability.
Introduction:
The American drug manufacturing industry has been for long a pioneer in the fields of innovation and research and has made a major contribution to the world’s health. These companies are contributing significantly for the betterment of society by providing the products and solutions for different kinds of health issues – starting from the infectious diseases to the chronic diseases – the world needs it and they are providing for it. Their work and research on discovery, invention, collaborations, and public access are leading to tackling some of the world most debilitating health challenges.
Research and Development (R&D) Efforts
Another approach in which American pharmaceutical companies are meeting global health issues is through the investment research and development or (R&D). They spend billions of dollars in the US alone every year in the research of new drugs, vaccines, and therapy. For example, in the COVID-19 circumstances, Pfizer as well as Moderna created vaccines at a high speed and distributed all over the world. This quick response shows appreciation of the fact that American pharma companies are capable of marshalling resources and professionals in responding to emerging urgent health threats.
More than the COVID-19, these companies are also looking at the products to prevent and treat diseases common in low- and middle-income countries such as malaria, tuberculosis, and HIV/AIDS. Pushing the research forward, American pharma companies increase the world’s efforts to fight infectious diseases.
Global Partnerships and Collaborations
In addressing global heath challenges, the use of collaboration has emerged strongly and more so saying American pharma firms are embracing collaborations with international organizations, governments and nonprofit organizations. Such collaborations assist in resource mobilization, information sharing and as such enhancing the production and distribution of affordable essential medicines.
For instance, partnership between Gilead Sciences and Medicines Patent Pool has enhanced access to HIV treatment in developing countries because its permits generic manufacturers to develop affordable drugs and distribute them promptly. Likewise, the Johnson & Johnson is collaborating with the international health bodies to overcome the neglected tropical diseases (NTDs) through supplying the necessary recoveries at cheap prices to the affected people.
Expanding Access to Medicines
Although a focus on new drug development is central to pharmaceutical innovation, getting new medicines to the people means as much. The pharma firms in America are playing a significant role to ensure several global populations get access to drugs especially in areas that this vice has not been practiced. Some of approaches used are, differentiated pricing where the drugs are cheaper in the less developed nations, donation where vital drugs are provided without charge.
For instance, Merck & Co’s Mectizan Donation Program has greatly contributed to fight against river blindness a disease that affects millions of people in Africa and Latin America. By implementing this programme, Merck has donated billions of the treatments thereby decreasing in incidence of the ailment and enhancing the lives of the affected individuals.
Addressing Chronic Diseases Globally
Non-communicable diseases including diabetes, cardiovascular and cancer diseases are on the rise globally with more and lighter incidence reported in the developing world. American pharmaceutical firms are at the forefront finding solutions to these chronic health conditions through research and innovation in chronic diseases treatments and international collaborations.
For example, Eli Lilly and Company has developed the Lilly NCD Partnership whose work consists of enhancing diabetes care and treatment in low- and middle-income countries. Training healthcare providers, community sensitisation about management of diabetes, as well as inexpensive insulin are all in the program. So, covering the chronic diseases on the global level, American pharma companies contribute to the decrease of the load of such diseases and increase of people’s health.
Innovation in Health Technology
Another area where American pharmaceutical firms are investing is the application of technology in healthcare sector.
The concept of digital health, telemedicine, and AI is creating the solutions from these companies that enrich the diagnosis, treatment, and monitoring of different diseases.
For instance, Abbott and Medtronic are crafting new sophisticated technologies in the form of medical devices that facilitate timely health-checks for patients in regions with little or no access to healthcare services due to their chronic diseases. Also, AI-based drug discovery solutions are helping in the development and discovery of new drugs and treatment methods especially for diseases that are considered to be complex with no set cause like cancers, and neurodegenerative diseases.
Sustainability and Ethical Practices
Combating global health issues is thus also about sustainability and espousing the right ethical position. There have been more measures and practices adopted in practicing sustainability in all aspect of their operations they include reduction of carbon emission, and better practice in product sourcing. They are all central in our quest to achieve sustainable gains in populace health and the global environment.
Furthermore, most of the companies or clinical research organizations, wish to perform ethical clinical trials especially in the third world countries taking care of the patients’ rights and welfare. American pharma companies are enhancing the credibility of its acts in the global health systems and processes by following ethical standards.
Conclusion
Pharmaceutical corporations are key drivers of change to global health regardless of their home countries, they are leaders in research, innovation, collaboration and have various initiatives in ensuring affordable access to medicine. These companies are not only enhancing the health of their respective nations and their people but also are the continuous investment in R&D, affiliating with global partners, and the gradual implementation of sustainable practices to make this world a better place to live. Such schemes are evidence to the importance of the pharmaceutical industry in addressing some of the critical health challenges affecting the human society today.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
